AVARA Rx review
The lower tirzepatide figure requires a discount code, which makes it a condition rather than a standing rate.
The verdict
AVARA Rx publishes compounded tirzepatide at $279 a month, or $229 with a code. The standing rate is $279. Compounded semaglutide is $229. The provider consult and shipping are stated as included in both.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- From $229/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
AVARA Rx sells compounded semaglutide and compounded tirzepatide. Both are weekly injections. The rates read $229 and $279 a month. A code lowers the tirzepatide rate to $229. Coverage is published as fifty states. No insurance is required.
Who writes the prescription, and what do they see?
The provider consult is stated as included in the price. It is not billed as a separate line. What the consult covers is not published beside either figure. Neither is how often it repeats. A prescription is required before the first shipment.
Care is arranged remotely. Shipping is described as free and discreet. One charge covers the medication, the consult and the postage. The two molecules are priced $50 apart at the standing rates. A code closes that gap on tirzepatide.
What happens when the dose goes up?
The dose-pricing model is not published on either row. Neither rate is described as flat. A reader should not assume the figure holds as the dose rises. The first sixteen weeks are an escalation for most patients. What a higher dose costs here is not stated.
What the price includes
$279 is the standing tirzepatide rate. $229 is the rate with the code. A code can be withdrawn without notice. The standing rate is the one to budget against. Semaglutide is $229 with no code attached. Nothing else was recorded beside either figure.
What it claims, and what it cites
Both products are compounded. A pharmacy prepares them. No regulator reviews the finished vial. A compounded preparation is not FDA-approved. The published trial results used the approved products at label doses. A compounded vial was not what those trials measured.
Where it holds up, and where it does not
- Strength: Consult and shipping stated as included
- Strength: Standing rate published beside the code rate
- Strength: Coverage published as fifty states
- Limitation: Lower tirzepatide rate depends on a code
- Limitation: Dose-pricing model not published
- Limitation: Consult scope not described
What the evidence says about this kind of treatment
The assessment above is about AVARA Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the consult inside the price. Both figures include it.
- Wrong for
- A reader budgeting on the code rate. A code is a condition, not a price.
The evidence behind what AVARA Rx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How AVARA Rx compares
| Seller | Who it suits | Go |
|---|---|---|
 KERNX Health | A reader who wants the clinician charge stated as a number before intake, and a medication rate that holds at every dose. | See KERNX Health → |
 NextMeds | A reader who wants one charge covering medication and care, at a rate stated to hold from the first order. | See NextMeds → |
 Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. | See Liberty → |
More GLP-1 telehealth sellers reviews: June HealthJustAnswer Weight LossJyra HealthKin MedsKinaKnownwell
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Which tirzepatide figure should a reader plan on?
- $279. That is the standing rate. The $229 figure requires a discount code, and a code can be withdrawn at any time.
- Is the consult charged separately?
- No. The provider consult and free shipping are stated as included in the published figures for both molecules.
- Does the price rise with the dose?
- Not published. Neither row describes the rate as flat, and no per-dose ladder is stated beside either figure.
- Is AVARA Rx expensive compared with other GLP-1 telehealth sellers?
- AVARA Rx publishes a starting figure of $229/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts AVARA Rx above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.